Self-assembling complexes from nucleic acids and synthetic polymers are eva
luated for plasmid and oligonucleotide (oligo) delivery. Polycations having
linear, branched, dendritic, block- or graft copolymer architectures are u
sed in these studies. All these molecules bind to nucleic acids due to form
ation of cooperative systems of salt bonds between the cationic groups of t
he polycation and phosphate groups of the DNA. To improve solubility of the
DNA/polycation complexes, cationic block and graft copolymers containing s
egments from polycations and non-ionic soluble polymers, for example, poly(
ethylene oxide) (PEO) were developed. Binding of these copolymers with shor
t DNA chains, such as oligos. results in formation of species containing hy
drophobic sites from neutralized DNA-polycation complex and hydrophilic sir
es from PEG. These species spontaneously associate into polyion complex mic
elles with a hydrophobic core from neutralized polyions and a hydrophilic s
hell from PEG. Such complexes are very small (10-40 nm) and stable in solut
ion despite complete neutralization of charge. They reveal significant acti
vity with oligos in vitro and in vivo. Binding of cationic copolymers to pl
asmid DNA forms larger (70-200 nm) complexes, which are practically inactiv
e in cell transfection studies. It is likely that PEO prevents binding of t
hese complexes with the cell membranes ("stealth effect"). However attachin
g specific ligands to the PEO-corona can produce complexes, which are both
stable in solution and bind to target cells. The most efficient complexes w
ere obtained when PEO in the cationic copolymer was replaced with membrane-
active PEO-b-poly( propylene oxide)-b-PEO molecules (Pluronic 123), Such co
mplexes exhibited elevated levels of transgene expression in liver followin
g systemic administration in mice, To increase stability of the complexes,
NanoGel(TM) carriers were developed that represent small hydrogel particles
synthesized by cross-linking of PEI with double end activated PEO using an
emulsification/solvent evaporation technique. Oligos are immobilized by mi
xing with NanoGel(TM) suspension. which results in the formation of small p
articles (80 nm). Oligos incorporated in NanoGel are able to reach targets
within the cell and suppress gene expression in a sequence-specific fashion
. Further, loaded NanoGel particles cross-polarized monolayers of intestina
l cells (Caco-2) suggesting potential usefulness of these systems for oral
administration of oligos. In conclusion the approaches using polycations fo
r gene delivery for the design of gene transfer complexes thar exhibit a ve
ry broad range of physicochemical and biological properties, which is essen
tial for design of a new generation of more effective non-viral gene delive
ry systems.